Your session is about to expire
← Back to Search
RNA-based Test
Colosense Test for Colorectal Cancer (CRC-PREVENT Trial)
N/A
Waitlist Available
Led By Faith Holmes, MD
Research Sponsored by Geneoscopy, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
CRC-PREVENT Trial Summary
This trial will assess a new test to detect colorectal cancer early. Results could save lives.
Eligible Conditions
- Colorectal Cancer
- Adenocarcinoma
- Colon Adenomas
- Colon Polyps
CRC-PREVENT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Colosense sensitivity for subjects with Advanced Adenoma (AA)
Colosense sensitivity for subjects with CRC
Colosense sensitivity for subjects with Other Adenomas (OAs)
+2 moreCRC-PREVENT Trial Design
1Treatment groups
Experimental Treatment
Group I: Colosense TestExperimental Treatment1 Intervention
All participants will be evaluated with the Colosense Test system and a colonoscopy.
Find a Location
Who is running the clinical trial?
Geneoscopy, Inc.Lead Sponsor
Faith Holmes, MDPrincipal InvestigatorElligo Health Research
Elizabeth Wurtzler, PhDStudy ChairGeneoscopy, Inc.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Colosense Test
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger